Sol_75H71026Q00134_Amd_0001.pdf

(x)

75H71026Q00134 x x

1 copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted ; or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGEMENT TO BE

RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR

OFFER. If by virtue of this amendment you desire to change an offer already submitted , such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

x

Tohatchi NM 87325 P.O. Box 142 Tohatchi Health CTR

07/27/20260001

13. THIS ITEM ONLY APPLIES TO MODIFICATION OF CONTRACTS/ORDERS. IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

12. ACCOUNTING AND APPROPRIATION DATA (If required) is not extended.is extended, Items 8 and 15, and returning

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended , by one of the following methods: (a) By completing

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

FACILITY CODE CODE

10B. DATED (SEE ITEM 13)

10A. MODIFICATION OF CONTRACT/ORDER NO.

9B. DATED (SEE ITEM 11)

9A. AMENDMENT OF SOLICITATION NO.

CODE

8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)

7. ADMINISTERED BY (If other than Item 6)CODE 6. ISSUED BY

PAGE OF PAGES

4. REQUISITION/PURCHASE REQ. NO.3. EFFECTIVE DATE2. AMENDMENT/MODIFICATION NO. 5. PROJECT NO. (If applicable)

1. CONTRACT ID CODE

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

07/27/2026

CHECK ONE A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER (Specify type of modification and authority) appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

E. IMPORTANT: Contractor is not is required to sign this document and return __________________ copies to the issuing office.

ORDER NO. IN ITEM 10A.

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

The purpose of Amendment 0001 is as follows:

1) Provide questions and answers.

2) Offerors must acknowledge this amendment and update their quotations accordingly DUE:

08/12/2025, 10:00 AM MD from Change due date 08/05/2025 10:00 AM MD

3) Small Business Set aside.

ALL OTHER TERMS AND CONDITION REMAIN UNCHANGED.

Period of Performance: 09/01/2026 to 08/31/2027

16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)15A. NAME AND TITLE OF SIGNER (Type or print)

15C. DATE SIGNED 16B. UNITED STATES OF AMERICA 15B. CONTRACTOR/OFFEROR 16C. DATE SIGNED

(Signature of person authorized to sign) (Signature of Contracting Officer)

MICHELLE A. JAMES

STANDARD FORM 30 (REV. 11/2016)

Prescribed by GSA FAR (48 CFR) 53.243

Previous edition unusable

Except as provided herein, all terms and conditions of the document referenced in Item 9 A or 10A, as heretofore changed, remains unchanged and in full force and effect .

75H71026Q00134 Questions and Anwers

1. QUESTION:

Container Inventory: Please provide the current number, size, and type of contractor-furnished pharmaceutical waste containers currently in service (hazardous pharmaceutical, non-hazardous pharmaceutical, and trace chemotherapy).

ANSWER: THC pharmacy currently has (12) 8-gallon hazardous bins

2. QUESTION:

Container Sizes: Please identify the required container sizes (e.g., 2-gallon, 5-gallon, 10-gallon, 17-gallon, 30-gallon, etc.) for each waste stream.

ANSWER: The size of the bins are 8-gallons

3. QUESTION:

Estimated Annual Volumes Please provide the estimated annual quantities or weights for:

o Hazardous pharmaceutical waste o Non-hazardous pharmaceutical waste o Trace chemotherapy waste

ANSWER : Estimated annual volumes: About 2 bins every 3 months and it is all classified as hazardous

4. QUESTION:

Pickup Frequency: Other than the requirement to replace full containers within 5–10 business days of notification, please provide the anticipated pickup frequency or estimated number of service events per year for each waste stream.

ANSWER: Pick up Frequency: 4 times a year - About once every 3 months.

5. QUESTION:

Waste Profiles: Will the Government provide current waste profiles and characterization information for the pharmaceutical waste streams, or is the contractor expected to perform the initial waste characterization and profiling?

ANSWER: The contractor is expected to perform the initial waste characterization and profiling

75H71026Q00134 Questions and Anwers

6. QUESTION:

I’m reaching out to gather additional details regarding your pharmaceutical waste so we can prepare an accurate quote. Could you please provide a detailed inventory of the materials you need disposed of, including the specific types and quantities? It would also be helpful to know the average frequency of disposal (weekly, biweekly, etc.). Any information you can share will assist us in tailoring the service to your needs.

ANSWER:

5.1 Pharmaceutical Waste Identification

The Contractor shall ensure an annual characterization of the facility’s pharmaceutical formulary that accurately identifies hazardous and non-hazardous pharmaceutical waste streams in accordance with applicable regulatory requirements.

5.2 Pharmaceutical Waste Container Management

The Contractor shall ensure the availability of compliant pharmaceutical waste containers that support proper segregation of waste, including:

• A single-container approach for most hazardous and non-hazardous pharmaceutical waste;

• Separate containers for incompatible pharmaceutical waste streams; and

• Separate containers for trace chemotherapy pharmaceutical waste, managed as regulated medical waste.

All containers shall meet applicable DOT and regulatory requirements

7. QUESTION:

Solicitation Set-Aside The solicitation posted on SAM.gov identifies this procurement as a Total Small Business Set-Aside. However, the SF-1449 appears to indicate the acquisition is unrestricted. Please confirm whether this procurement is intended to remain a Total Small Business Set-Aside and whether the SF-1449 will be revised to reflect the intended set-aside status

ANSWER: Is a Small Business Set-aside as its noted in the SAM.gov posting.